Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03444675
Other study ID # GBG18001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 29, 2014
Est. completion date May 1, 2023

Study information

Verified date May 2020
Source Sahlgrenska University Hospital, Sweden
Contact Mihai Oltean, M.D., Ph.D.
Phone 00 46 31 342 1000
Email mihai.oltean@surgery.gu.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study validates prospectively a new endoscopic scoring system (Gothenburg Intestinal Transplant Endoscopy Score, GITES) designed to summarize and stratify the abnormal ileal endoscopic findings after intestinal transplantation. GITES is a five-tier, four grade score which asseses mucosal friability, mucosal erythema and mucosal injury (ulcerations) as well as villous changes according to severity. These features (i.e., endoscopic descriptors) are also grouped from mild to very severe in the same sequence as observed during the progression of several pathologic conditions encountered after intestinal transplantation (acute rejection, infectious enteritis).


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date May 1, 2023
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- transplantation of a segment of small intestine (as isolated graft or together with other organs)

Exclusion Criteria:

- contraindications for ileoscopy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Argentina Favaloro Foundation University Hospital Buenos Aires
Spain Hospital Universitario "La Paz" Madrid
Sweden Sahlgrenska University Hospital Gothenburg
United States MedStar Georgetown University Hospital Washington District of Columbia

Sponsors (5)

Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden Favaloro Foundation University Hospital, Buenos Aires, Argentina, Hospital Universitario La Paz, MedStar Georgetown University Hospital, Washington DC, Sahlgrenska University Hospital, Gothenburg, Sweden

Countries where clinical trial is conducted

United States,  Argentina,  Spain,  Sweden, 

References & Publications (3)

Sigurdsson L, Reyes J, Putnam PE, del Rosario JF, Di Lorenzo C, Orenstein SR, Todo S, Kocoshis SA. Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol. 1998 Feb;93(2):207-11. — View Citation

Tabasco-Minguillán J, Weber K, Nelson F, Hutson W, Furukawa H, Abu-Elmagd K, Todo S, Rakela J. Variability in the interpretations of endoscopic findings in patients with intestinal transplantation. Transplant Proc. 1996 Oct;28(5):2775-6. — View Citation

Varkey J, Stotzer PO, Simrén M, Herlenius G, Oltean M. The endoscopic surveillance of the transplanted small intestine: a single center experience and a proposal for a grading score. Scand J Gastroenterol. 2018 Feb;53(2):134-139. doi: 10.1080/00365521.2017.1411523. Epub 2017 Dec 12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Endoscopic evaluation To validate the GITES grading system in intestinal graft recipients using high-definition white light endoscopy 7 years
Secondary Correlations with histology and Clinical course Comparison and correlation of clinical and histopathological data with endoscopic findings to evaluate the conditions leading to the mucosal alterations defined by established endoscopic descriptors and GITES. 1 year
Secondary Performance of the grading score Endpoints include sensitivity, specificity, positive predictive value, negative predictive value as well as inter- and intraobserver variation in the evaluation of the mucosal alterations by means of GITES and using high-definition white light endoscopy; 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04496037 - Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant
Completed NCT01354301 - Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate Phase 4
Recruiting NCT03172091 - Volatile Organic Compounds as Markers of Acute Rejection in Lung Transplant N/A
Completed NCT04019353 - Cf-DNA Assay During Treatment of Acute Rejection
Recruiting NCT04855422 - Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
Recruiting NCT03422224 - ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation
Active, not recruiting NCT03882164 - Blood-Bile Ratio Tacrolimus After Liver Transplantation
Not yet recruiting NCT05951231 - Liver Transplantation After ex Vivo Liver Perfusion N/A
Enrolling by invitation NCT04234139 - Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation